Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kayleigh R. Marx
Clinical Experience With the BCL2-inhibitor Venetoclax in Combination Therapy for Relapsed and Refractory Acute Myeloid Leukemia and Related Myeloid Malignancies
American Journal of Hematology
Hematology
Related publications
Low Dose Cytarabine and Cladribine for Treatment of Relapsed or Refractory Acute Myeloid Leukemia: Clinical Experience
Klinicheskaya Onkogematologiya/Clinical Oncohematology
Oncology
Hematology
The mTOR Inhibitor Everolimus in Combination With Azacitidine in Patients With Relapsed/Refractory Acute Myeloid Leukemia: A Phase Ib/Ii Study
Oncotarget
Oncology
Therapy-Related Myelodysplasia and Acute Myeloid Leukemia
Seminars in Oncology
Oncology
Hematology
Timed Sequential Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia
Clinical Hematology International
Salvage Treatment for Refractory or Relapsed Acute Myeloid Leukemia: A 10-Year Single-Center Experience
Clinics
Medicine
Bevacizumab Reduces VEGF Expression in Patients With Relapsed and Refractory Acute Myeloid Leukemia Without Clinical Antileukemic Activity
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
A Phase I Study of Carfilzomib for Relapsed or Refractory Acute Myeloid and Acute Lymphoblastic Leukemia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Therapy-Related Myeloid Leukemia
Seminars in Oncology
Oncology
Hematology
Bortezomib Combination Therapy of Relapsed and Refractory Acute Lymphoblastic Leukemia in Children
Klinicheskaya Onkogematologiya/Clinical Oncohematology
Oncology
Hematology
